Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma

Oncology Letters

Volumn 1, Issue 5, 2010, Pages 899-903

  Zhang, Peng ^a   Han, Yi Ping ^a   Huang, Ling ^a   Li, Qiang ^a   Ma, Da Lie ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Lung cancer; Napsin a; Thyroid transcription factor 1

Indexed keywords

ASPARTIC PROTEINASE; NAPSIN 1 PROTEINASE; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERFORMANCE MEASUREMENT SYSTEM; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMALL CELL CARCINOMA; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; THYROID CARCINOMA; TUMOR VOLUME;

EID: 77957583034     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_00000160     Document Type: Article

References (20)

1. Weir HK, Thun MJ, Hankey BF, et al: Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95: 1276-1299, 1998.
2. Tatnell PJ, Powell DJ, Hill J, et al: Napsins: new human aspartic proteinases. Distinction between two closely related genes. FEBS Lett 441: 43-48, 1998.
3. Chuman Y, Bergman A, Ueno T, et al: Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas. FEBS Lett 462: 129-134, 1999.
4. Schauer-Vukasinovic V, Bur D, Kling D, et al: Human napsin A: expression, immunochemical detection and tissue localization. FEBS Lett 462: 135-139, 1999.
5. Brasch F, Ochs M, Kahne T, et al: Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung. J Biol Chem 278: 49006-49014, 2003.
6. Ueno T, Linder S and Elmberger G: Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma. Br J Cancer 88: 1229-1233, 2003.
7. Hirano T, Gong Y, Yoshida K, et al: Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma. Lung Cancer 41: 155-162, 2003.
8. Jagirdar J: Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med 132: 384-396, 2008.
9. Chang YL, Lee YC, Liao WY, et al: The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer 44: 149-157, 2004.
10. Hirano T, Franzén B, Uryu K, et al: Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma. Br J Cancer 72: 840-848, 1995.
11. Hirano T, Fujioka K, Franzén B, et al: Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features. Br J Cancer 75: 978-985, 1997.
12. Hirano T, Auer G, Maeda M, et al: Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A. Jpn J Cancer Res 91: 1015-1021, 2000.
13. Suzuki A, Shijubo N, Yamada G, et al: Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs. Pathol Res Pract 201: 579-586, 2005.
14. Ueno T, Linder S, Na CL, et al: Processing of pulmonary surfactant protein B by napsin and cathepsin H. J Biol Chem 279: 16178-16184, 2004.
15. Ueno T, Elmberger G, Weaver TE, et al: The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity. Lab Invest 88: 256-263, 2008.
16. Bruno MD, Bohinski RJ, Huelsman KM, et al: Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription factor-1. J Biol Chem 270: 6531-6536, 1995.
17. Barlési F, Pinot D, Legoffic A, et al: Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung. Br J Cancer 93: 450-452, 2005.
18. Berghmans T, Paesmans M, Mascaux C, et al: Thyroid transcription factor 1 - a new prognostic factor in lung cancer: a meta-analysis. Ann Oncol 17: 1673-1676, 2006.
19. Tan D, Li Q, Deeb G, et al: Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immuno-histochemistry study. Hum Pathol 34: 597-604, 2003.
20. Kaufmann O and Dietel M: Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 36: 415-420, 2000.